BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9852905)

  • 1. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning.
    Meldrum DR; Dinarello CA; Shames BD; Cleveland JC; Cain BS; Banerjee A; Meng X; Harken AH
    Circulation; 1998 Nov; 98(19 Suppl):II214-8; discussion II218-9. PubMed ID: 9852905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine reduces cardiac TNF-alpha production and human myocardial injury following ischemia-reperfusion.
    Cain BS; Meldrum DR; Dinarello CA; Meng X; Banerjee A; Harken AH
    J Surg Res; 1998 May; 76(2):117-23. PubMed ID: 9698510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation.
    Meldrum DR; Cain BS; Cleveland JC; Meng X; Ayala A; Banerjee A; Harken AH
    Immunology; 1997 Dec; 92(4):472-7. PubMed ID: 9497488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis.
    Sharony R; Frolkis I; Froylich D; Wildhirt SM; Shapira I; Reichart B; Nesher N; Uretzky G
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):501-7. PubMed ID: 15740963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin addition after ischemia improves recovery of function equal to ischemic preconditioning in rat heart.
    Fischer-Rasokat U; Beyersdorf F; Doenst T
    Basic Res Cardiol; 2003 Sep; 98(5):329-36. PubMed ID: 12955406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial protection by ischemic preconditioning and delta-opioid receptor activation in the isolated working rat heart.
    Karck M; Tanaka S; Bolling SF; Simon A; Su TP; Oeltgen PR; Haverich A
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):986-92. PubMed ID: 11689805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart.
    Li C; Ha T; Liu L; Browder W; Kao RL
    Surgery; 2000 Feb; 127(2):161-9. PubMed ID: 10686981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium preconditioning, but not ischemic preconditioning, bypasses the adenosine triphosphate-dependent potassium (KATP) channel.
    Meldrum DR; Cain BS; Meng X; Cleveland JC; Shames BD; Donnahoo KK; Banerjee A; Harken AH
    J Surg Res; 1999 Jul; 85(1):77-82. PubMed ID: 10383841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free radicals trigger TNF alpha-induced cardioprotection.
    Lecour S; Rochette L; Opie L
    Cardiovasc Res; 2005 Jan; 65(1):239-43. PubMed ID: 15621052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia.
    Wang M; Tsai BM; Crisostomo PR; Meldrum DR
    Shock; 2006 May; 25(5):454-9. PubMed ID: 16680009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha.
    Xu Y; Arenas IA; Armstrong SJ; Plahta WC; Xu H; Davidge ST
    Cardiovasc Res; 2006 Mar; 69(4):836-44. PubMed ID: 16403479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
    Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R
    J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de novo protein synthesis.
    Rowland RT; Meng X; Cleveland JC; Meldrum DR; Harken AH; Brown JM
    J Surg Res; 1997 Aug; 71(2):155-60. PubMed ID: 9299284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha is required for late ischemic preconditioning but not for remote preconditioning of trauma.
    Ren X; Wang Y; Jones WK
    J Surg Res; 2004 Sep; 121(1):120-9. PubMed ID: 15313385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual dimorphism in myocardial tumor necrosis factor-alpha and cardiac function during endotoxin tolerance.
    Pitcher JM; Tsai BM; Wang M; Kher A; Brown JW; Meldrum DR
    Surgery; 2005 Aug; 138(2):223-8. PubMed ID: 16153430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditioning decreases ischemia/reperfusion-induced peroxynitrite formation.
    Csonka C; Csont T; Onody A; Ferdinandy P
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1217-9. PubMed ID: 11478785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection.
    Lecour S; Smith RM; Woodward B; Opie LH; Rochette L; Sack MN
    J Mol Cell Cardiol; 2002 May; 34(5):509-18. PubMed ID: 12056855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
    Lecour S; Suleman N; Deuchar GA; Somers S; Lacerda L; Huisamen B; Opie LH
    Circulation; 2005 Dec; 112(25):3911-8. PubMed ID: 16344382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of specific ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning.
    Beresewicz A; Dobrzyń A; Górski J
    J Physiol Pharmacol; 2002 Sep; 53(3):371-82. PubMed ID: 12369735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.